Gradalis Company
.jpg)
Gradalis is engaged in manufacturing immunotherapy for the treatment of cancer.
Total Funding:
$67 936 167
Headquarters:
Carrollton, Texas, United States
Estimated Revenue:
$1M to $10M
Last Funding Type:
Venture - Series Unknown
Last Funding Date:
2018-04-02
Founded Date:
2003-01-01
Industry:
Women Cancer Treatment